Stay updated on Pembrolizumab in Esophagogastric Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Esophagogastric Cancer Clinical Trial page.

Latest updates to the Pembrolizumab in Esophagogastric Cancer Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedFooter now includes Revision: v3.3.3 and removes HHS Vulnerability Disclosure and Revision: v3.3.2. This update does not affect study details or functionality; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check40 days agoChange DetectedPublications description now states that items are automatically filled from PubMed, and the revision tag changed from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check47 days agoChange DetectedRemoved the general government funding/status notice banner; this site-wide notice did not affect the study details or participation. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check61 days agoChange DetectedThe new screenshot shows the same study details page with only minor layout and typography adjustments; no substantive content such as eligibility criteria, endpoints, or study results appears to have changed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check90 days agoChange Detected- Added a government operating status notice and new version (v3.2.0). - Removed a specific resource (Carcinoma of esophagus) and the old version tag (v3.1.0).SummaryDifference4%

- Check97 days agoChange Detected- Updated version from v3.0.2 to v3.1.0. - No other content changes detected.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab in Esophagogastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Esophagogastric Cancer Clinical Trial page.